Hislop Colin - Net Worth and Insider Trading

Hislop Colin Net Worth

The estimated net worth of Hislop Colin is at least $159 dollars as of 2024-11-13. Hislop Colin is the Chief Medical Officer of Aravive Inc and owns about 3,972 shares of Aravive Inc (ARAV) stock worth over $159. Details can be seen in Hislop Colin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hislop Colin has not made any transactions after 2017-10-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Hislop Colin

To

Hislop Colin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hislop Colin owns 2 companies in total, including Aravive Inc (ARAV) , and Anthera Pharmaceuticals Inc (ANTH) .

Click here to see the complete history of Hislop Colin’s form 4 insider trades.

Insider Ownership Summary of Hislop Colin

Ticker Comapny Transaction Date Type of Owner
ARAV Aravive Inc 2017-10-19 Chief Medical Officer
ANTH Anthera Pharmaceuticals Inc 2016-02-12 Chief Medical Officer

Hislop Colin Latest Holdings Summary

Hislop Colin currently owns a total of 1 stock. Hislop Colin owns 3,972 shares of Aravive Inc (ARAV) as of October 19, 2017, with a value of $159.

Latest Holdings of Hislop Colin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARAV Aravive Inc 2017-10-19 3,972 0.04 159

Holding Weightings of Hislop Colin


Hislop Colin Form 4 Trading Tracker

According to the SEC Form 4 filings, Hislop Colin has made a total of 0 transactions in Aravive Inc (ARAV) over the past 5 years. The most-recent trade in Aravive Inc is the sale of 111 shares on October 19, 2017, which brought Hislop Colin around $1,701.

Insider Trading History of Hislop Colin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hislop Colin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hislop Colin Ownership Network

Ownership Network List of Hislop Colin

No Data

Ownership Network Relation of Hislop Colin

Insider Network Chart

Hislop Colin Owned Company Details

What does Aravive Inc do?

Who are the key executives at Aravive Inc?

Hislop Colin is the Chief Medical Officer of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .

Aravive Inc (ARAV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aravive Inc Insider Transactions

No Available Data

Hislop Colin Mailing Address

Above is the net worth, insider trading, and ownership report for Hislop Colin. You might contact Hislop Colin via mailing address: C/o Peninsula Pharmaceuticals, Inc., 1751 Harbor Bay Parkway, Alameda Ca 94502.